What we found for the very first time, after three and a half to four years of treatment, is that if we add semaglutide to that individual, we can reduce their chance of either dying of cardiovascular disease, having a second stroke, or a second heart attack by 20%
Combination therapies Besides the combination therapies described above, in patients with bridging fibrosis and cirrhosis, combining cilofexor (ACC inhibitor) and firsocostat (FXR agonist) for 48 weeks was well tolerated, showed beneficial effects on MASH disease parameters, and might improve fibrosis
While I would recommend any team member, I would strongly urge you to speak with Mrs
These trials are running now
That is also why retatrutide keeps winning comparison traffic against established names, whether the comparison is tirzepatide, semaglutide, or even other peptide categories